Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: An open-label trial

Eduardo Leiderman, Ilana Zylberman, Stephen R. Zukin, Thomas B. Cooper, Daniel C. Javitt

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)213-215
Number of pages3
JournalBiological Psychiatry
Volume39
Issue number3
DOIs
StatePublished - Feb 1 1996
Externally publishedYes

Fingerprint

N-Methyl-D-Aspartate Receptors
Glycine
Glutamic Acid
Schizophrenia
Serum

Keywords

  • Glutamate
  • NMDA receptor
  • Phencyclidine (PCP) treatment
  • Positive and Negative Syndrome Scale (PANSS)

ASJC Scopus subject areas

  • Biological Psychiatry

Cite this

Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia : An open-label trial. / Leiderman, Eduardo; Zylberman, Ilana; Zukin, Stephen R.; Cooper, Thomas B.; Javitt, Daniel C.

In: Biological Psychiatry, Vol. 39, No. 3, 01.02.1996, p. 213-215.

Research output: Contribution to journalArticle

Leiderman, Eduardo ; Zylberman, Ilana ; Zukin, Stephen R. ; Cooper, Thomas B. ; Javitt, Daniel C. / Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia : An open-label trial. In: Biological Psychiatry. 1996 ; Vol. 39, No. 3. pp. 213-215.
@article{cd6abfeb9b264d34bdca7ab139262bd9,
title = "Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: An open-label trial",
keywords = "Glutamate, NMDA receptor, Phencyclidine (PCP) treatment, Positive and Negative Syndrome Scale (PANSS)",
author = "Eduardo Leiderman and Ilana Zylberman and Zukin, {Stephen R.} and Cooper, {Thomas B.} and Javitt, {Daniel C.}",
year = "1996",
month = "2",
day = "1",
doi = "10.1016/0006-3223(95)00585-4",
language = "English (US)",
volume = "39",
pages = "213--215",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",
number = "3",

}

TY - JOUR

T1 - Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia

T2 - An open-label trial

AU - Leiderman, Eduardo

AU - Zylberman, Ilana

AU - Zukin, Stephen R.

AU - Cooper, Thomas B.

AU - Javitt, Daniel C.

PY - 1996/2/1

Y1 - 1996/2/1

KW - Glutamate

KW - NMDA receptor

KW - Phencyclidine (PCP) treatment

KW - Positive and Negative Syndrome Scale (PANSS)

UR - http://www.scopus.com/inward/record.url?scp=0030032401&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030032401&partnerID=8YFLogxK

U2 - 10.1016/0006-3223(95)00585-4

DO - 10.1016/0006-3223(95)00585-4

M3 - Article

C2 - 8837983

AN - SCOPUS:0030032401

VL - 39

SP - 213

EP - 215

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 3

ER -